Drawing for BIAMUS

USPTO serial 88383583

BIAMUS

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIAMUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachelle A. Dubow, Esq.

Rachelle A. Dubow, Esq. Morgan, Lewis & Bockius LLPOne Federal StreetBoston, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for medical purposes used to maintain health or restore health to a human or animal subject through treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives for medical purposes in the nature of microorganisms derived from animals, including humans; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms for medical purposes used to maintain health or restore health to a human or animal subject through treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary useABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2020MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jun 26, 2020ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 22, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 15, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 15, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 15, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 15, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 24, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 17, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2020ALIEASSIGNED TO LIE—
Jan 9, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 9, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 9, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2019DOCKASSIGNED TO EXAMINER—
Apr 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance